Insider Buying: Croda International (LON:CRDA) Insider Purchases £164.60 in Stock

Key Points

• Insider activity: Croda International insider Stephen Oxley purchased 5 shares for £164.60, following several similar small purchases but also a sale of 1,339 shares worth £43,035.46 earlier in August.
• Stock performance: Croda shares opened at GBX 3,274, near their 52-week high of GBX 3,352, with a market capitalization of approximately £4.56 billion and a P/E ratio of 57.54.
• Analyst outlook: Analysts maintain a consensus “Moderate Buy” rating with an average target price of GBX 3,390; the company recently reported quarterly EPS of GBX 72.20.

Croda International Plc (LON:CRDA - Get Free Report) insider Stephen Oxley acquired 5 shares of the firm's stock in a transaction on Monday, August 10th. The stock was bought at an average price of GBX 3,292 per share, with a total value of £164.60.

Stephen Oxley also recently made the following trade(s):

• On Monday, August 3rd, Stephen Oxley sold 1,339 shares of Croda International stock. The stock was sold at an average price of GBX 3,214, for a total transaction of £43,035.46.
• On Friday, July 10th, Stephen Oxley acquired 5 shares of Croda International stock. The shares were purchased at an average cost of GBX 2,859 per share, for a total transaction of £142.95.
• On Wednesday, June 10th, Stephen Oxley purchased 5 shares of Croda International stock. The stock was acquired at an average price of GBX 2,965 per share, with a total value of £148.25.

Croda International Price Performance

Shares of LON CRDA opened at GBX 3,274 on Tuesday. The company has a debt-to-equity ratio of 36.06, a quick ratio of 2.25 and a current ratio of 2.57. The company has a 50 day simple moving average of GBX 3,041.96 and a two-hundred day simple moving average of GBX 2,935.61. Croda International Plc has a fifty-two week low of GBX 2,426.77 and a fifty-two week high of GBX 3,352. The company has a market capitalization of £4.56 billion, a price-to-earnings ratio of 57.54, a P/E/G ratio of 1.40 and a beta of 0.92.

Croda International (LON:CRDA - Get Free Report) last announced its quarterly earnings data on Tuesday, July 28th. The company reported GBX 72.20 EPS for the quarter. Croda International had a net margin of 4.61% and a return on equity of 3.65%. Analysts expect that Croda International Plc will post 181.8307268 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

CRDA has been the topic of several research reports. Jefferies Financial Group restated a "buy" rating and issued a GBX 3,500 target price on shares of Croda International in a report on Wednesday, July 29th. Citigroup lifted their price target on shares of Croda International from GBX 3,050 to GBX 3,200 and gave the stock a "neutral" rating in a research note on Wednesday, July 29th. Berenberg Bank reissued a "buy" rating and set a GBX 3,600 price target on shares of Croda International in a report on Wednesday, July 29th. Finally, Deutsche Bank Aktiengesellschaft reiterated a "hold" rating and set a GBX 3,300 price objective on shares of Croda International in a research note on Wednesday, July 29th. Three investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of GBX 3,390.

Croda International Company Profile

Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world. Sustainability is a core part of the Groups strategy with a commitment to be Climate, Land and People positive by 2030.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source